BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1696803)

  • 1. [Chemosynthetic peptides against foot-and-mouth disease--immune response to free and carrier bound peptides of the VP1 of O1-Kaufbeuren].
    Liebermann H; Reimann I; Bartels T; Nöckler A; Thalmann G; Furkert J; Dölling R
    Arch Exp Veterinarmed; 1990; 44(2):189-97. PubMed ID: 1696803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
    Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
    Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the influence of peptide-carrier conjugation on the immunological activity of VP1-peptides of foot-and-mouth disease virus O1-Kaufbeuren.
    Furkert J; Dölling R; Liebermann H; Penke B
    Arch Exp Veterinarmed; 1990; 44(6):873-81. PubMed ID: 1966359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
    Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
    Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of immune responses in the sheep to synthetic peptides of foot-and-mouth disease virus using ovine polyclonal and monoclonal antibodies.
    Flynn JN; Harkiss GD; Doel T; DiMarchi R
    Immunology; 1990 Jan; 69(1):1-7. PubMed ID: 1690176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthetic peptides simulating the protective epitopes of VP1 protein of foot-and-mouth disease virus type O and A].
    Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN
    Bioorg Khim; 1987 Aug; 13(8):1132-5. PubMed ID: 2445357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example.
    Vol'pina OM; Surovoi AYu ; Ivanov VT
    Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigenic structure of foot-and-mouth virus. IV. Synthesis and immunogenic properties of new fragments of the VP1 protein of food-and-mouth virus strain A22].
    Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Lugovskoĭ AA; Driagalin NN; Ivaniushchenkov VN
    Bioorg Khim; 1989 Sep; 15(9):1193-205. PubMed ID: 2556150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
    Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
    Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
    Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
    Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis and immunogenic properties of peptides--fragments of the immunodominant regions of the VP1 protein of the Asia-1 type of foot- and-mouth disease virus].
    Petrov VN; Rybakov SS; Petrova ON; Chepurkin AV; Gulenkin VM
    Bioorg Khim; 1998 Dec; 24(12):899-905. PubMed ID: 10079947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles.
    Parry NR; Syred A; Rowlands DJ; Brown F
    Immunology; 1988 Aug; 64(4):567-72. PubMed ID: 2844657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.
    van Lierop MJ; van Maanen K; Meloen RH; Rutten VP; de Jong MA; Hensen EJ
    Immunology; 1992 Mar; 75(3):406-13. PubMed ID: 1349300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines.
    Morgan DO; Moore DM
    Am J Vet Res; 1990 Jan; 51(1):40-5. PubMed ID: 2154148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to uncoupled peptides of foot-and-mouth disease virus.
    Francis MJ; Fry CM; Rowlands DJ; Bittle JL; Houghten RA; Lerner RA; Brown F
    Immunology; 1987 May; 61(1):1-6. PubMed ID: 3034769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenic structure of the foot-and-mouth virus. VI. Functional segments of the immunodominant region of the VP1 protein of foot-and-mouth virus strains O1K and A22].
    Gel'famov VM; Grechaninova LA; Kan ES; Iarov AV; Surovoĭ AIu; Vol'pina OM; Chepurkin AV; Ivanov VT
    Bioorg Khim; 1991 May; 17(5):596-605. PubMed ID: 1722673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide vaccine--a new approach to a safer foot-and-mouth disease virus vaccine.
    Pfaff E; Thiel HJ; Böhm HO; Leban J
    Arzneimittelforschung; 1987 Jan; 37(1):82-6. PubMed ID: 3032213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.
    Clarke BE; Newton SE; Carroll AR; Francis MJ; Appleyard G; Syred AD; Highfield PE; Rowlands DJ; Brown F
    Nature; 1987 Nov 26-Dec 2; 330(6146):381-4. PubMed ID: 2446137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.